Home
|
Inbox
|
Search
|
Speaker
Stefano Petruzzelli
MD, PhD
Chiesi Farmaceutici;Chiesi Farmaceutici S.p.a.
Session(s)
- Single Inhaler Extrafine Triple Therapy Reduces Clinically Important Deterioration (CID) i...
Sunday, May 20 10:15 AM - 10:30 AM - Extrafine Formulation of Beclometasone Dipropionate, Formoterol Fumarate, Glycopyrronium (...
Monday, May 21 11:15 AM - 1:00 PM - Reduction in Fatal Events with ICS-containing Medications: Results of Safety Pooled Analys...
Monday, May 21 11:15 AM - 1:00 PM - Risk of Pneumonia and Exacerbations with Single Inhaler Extrafine Triple Therapy Compared ...
Monday, May 21 11:15 AM - 1:00 PM - Single Inhaler Extrafine Triple Therapy Improves Clinical Outcomes in Gold B COPD Patients...
Monday, May 21 11:15 AM - 1:00 PM - Single Inhaler Extrafine Triple Therapy Vs Indacaterol/Glycopyrronium in COPD Patients Pre...
Monday, May 21 11:15 AM - 1:00 PM - Single Inhaler Extrafine Triple Therapy Improves Quality of Life in COPD Patients Compared...
Monday, May 21 2:15 PM - 4:15 PM
|
Home
|
Inbox
|
Search
|